explore -WSS

explore

author：leisure time 2025-10-02 07:45:05 - browse：625

Cynthia Fisher on stage at the 2023 STAT Summit. — Cynthia Fisher, founder and chairman, PatientRightsAdvocate.org STAT

BOSTON — For all those who think hospital price transparency will not save money, Cynthia Fisher has a message: it’s already doing so.

Fisher, who spoke Wednesday at the annual STAT Summit in Boston, is the successful entrepreneur and founder of PatientRightsAdvocate.org who has been leading an unorthodox campaign to get hospitals to disclose prices.

The campaign has made progress. Republicans on three House committees introduced a bill to make hospitals disclose prices up front, though then-House Speaker Kevin McCarthy (R-Calif.) pulled the bill shortly before it was supposed to receive a vote on the House floor.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Congress must reauthorize a committee to support older Americans

WSS

Bird flu: Don't repeat Covid's 'health versus the economy' framing

NVIDIA and Google execs on the future of AI and drug discovery

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

PBM reforms clear House panel

entertainment

explore

focus

Duchenne breakthrough therapy leaves behind pioneering families

Helping hospitals and community health centers plan for resilience

Walensky prepares to leave CDC — and Congress — behind

Readers respond to H5N1 and livestock movements, and more

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Novavax promises a turnaround & Lilly roils the obesity market

Case highlights the risks of experimental stem cell therapy

Novavax promises a turnaround & Lilly roils the obesity market

Poor hospice wound care hurts patients and families

leisure time

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Hospitals look to new technology to keep health care workers safe

Big Tobacco's 'harm reduction': Is it for real, or a sham?

In key trial, Verve's treatment lowers cholesterol levels in patients

With measles on the rise, a personal story of a devastating disease

focus

leisure time

leisure time

leisure time